Acquired aortic stenosis

Expert Review of Cardiovascular Therapy

Volumn 2, Issue 1, 2004, Pages 107-116

  Freeman, Rosario V ^a   Crittenden, Gretchen ^a   Otto, Catherine ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic stenosis; Vascular disease

Indexed keywords

AMOXICILLIN; AMPICIL; AMPICILLIN; AZITHROMYCIN; BIACIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CLARITHROMYCIN; CLINDAMYCIN; ZITHROMYCIN; ANTIINFECTIVE AGENT;

AORTA STENOSIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; ENDOCARDITIS; EXERCISE TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEMODYNAMIC MONITORING; HUMAN; HYPERLIPIDEMIA; LATENT PERIOD; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; THROMBOEMBOLISM; TREATMENT OUTCOME; ADULT; AGED; CALCINOSIS; ECHOGRAPHY; FEMALE; PREGNANCY; SUDDEN DEATH;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AORTIC VALVE STENOSIS; CALCINOSIS; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; PREGNANCY;

EID: 2342444566     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.2.1.107     Document Type: Review

References (111)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220-1225 (1993).
2. Bonow RO, Antonio C, de Leon J et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J. Am. Coll. Cardiol. 32, 1486-1588 (1998).
3. Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ. Accelerated progression of calcific aortic stenosis in dialysis patients. Nepron Clin. Pract. 94, C40-C45 (2003).
4. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104, 2205-2209 (2001).
5. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am. J. Cardiol. 88, 693-695 (2001).
6. Chui MC, Newby DE, Panarelli M, Bloomfield P, Boon N. Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin. Cardiol. 24, 52-55 (2002).
7. Faggiano P, Antonini-Canterin F, Erlicher A, Romeo C et al. Progression of aortic valve sclerosis to aortic stenosis. Am. J. Cardiol. 91, 99-101 (2003).
8. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 341, 142-147 (1999).
9. Stewart BF, Siscovick D, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J. Am. Coll. Cardiol. 29, 630-634 (1997).
10. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am. J. Cardiol. 59, 998-999 (1987).
11. Palta S. New insights into the progression of aortic stenosis. Circulation 101, 2497-2502 (2000).
12. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 85, 601-602 (2001).
13. Peltier M, Trojette F, Sarano ME et al. Relation between cardiovascular risk factors and nonrhematic severe calcific aortic stenosis among patients with three cuspid aortic valve. Am. J. Cardiol. 91 (2003).
14. Beppu S, Suzuki S, Matsuda H et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am. J. Cardiol. 71, 322-327 (1993).
15. Pachulski RT. Chan KL. Progression of aortic valve dysfunction in 51 adult patients with congenital bicuspid aortic valve assessment and follow-up by doppler echocardiogaphy. Br. Heart. J. 69, 237-240 (1993).
16. Chan KL, Ghani M, Woodend K, Burwash I. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am. J. Cardiol. 88, 690-693 (2001).
17. Selzer A. Changing aspects of natural history of valvular aortic stenosis. N. Engl. J. Med. 317, 91-98 (1987).
18. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur. Heart J. 9(Suppl.), E57-E64 (1988).
19. Eisenberg MJ. Rheumatic heart disease in the developed world: prevalence, prevention and control. Eur. Heart J. 14, 122-128 (1993).
20. Shavelle DM OC. Aortic Stenosis. From Cardiology Harcourt Health Systems.
21. Otto CM. Aortic Stenosis - Listen to the Patient, Look at the Valve. N. Engl. J. Med. 343, 652-654 (2000).
22. Otto CM Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion in "degenerative" valvular aortic stenosis: histological and immunohistochemical studies. Circulation 90, 844-853 (1994).
23. O'Brien KD, Kuusisto J, Reichenbach DD et al. Osteopontin is expressed in human aortic valvular lesions. Circulation, 92, 2163-2168 (1995).
24. Olsson M, Thybery J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic: stenotic aortic valves. Arterioscler. Thromb. Vasc. Biol. 19, 1218-1222 (1999).
25. Mohler ER III, Chawla MK, Chang AW et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J. Heart Valve Dis. 8, 254-260 (1999).
26. Chan KL. Is Aortic Stenosis a Preventable Disease? J. Am. Coll. Cardiol. 42, 593-599 (2003).
27. Rajamannan NM, Subramaniam M, Springett M et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105 (2002).
28. Douglas PS OC, Mickel MC, Labovitz A, Reid CL, Davis KB. Gender differences in left ventricular geometry and function in patients undergoing balloon dilation of the aortic valve for isolated aortic stenosis. Br. Heart J. 73(6), 548-554 (1995).
29. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. J. Am. Coll. Cardiol. 74, 794-798 (1994).
30. Douglas PS, Berko B, Lesh M, Reichek N. Alterations in diastolic function in response to progressive left ventricular hypertrophy. J. Am. Coll. Cardiol. 13, 461-467 (1989).
31. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur. Heart J. 9(Suppl.), E19-E23 (1988).
32. Carabello BA, Green LH, Grossman W et al. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 62, 42-48 (1980).
33. Kuhl HP, Franke A, Puschmann et al. Regression of left ventricular mass one year after aortic valve replacement for pure aortic stenosis. Am. J. Cardiol. 89, 408-413 (2002).
34. Christakis GT, Joyner CD, Morgan CD et al. Left ventricular mass regression early after aortic valve replacement. Ann. Thorac. Surg. 62, 1084-1089 (1996).
35. Kelly TA, Rothbart RM, Cooper CM et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am. J. Cardiol. 61, 123-130 (1988).
36. Julius BK SM, Vassalli G, Villari B et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiolgical concepts. Circulation 95, 892-898 (1997).
37. Rajappan K Rimoldi OE, Camici PG et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 105, 470-476 (2002).
38. Gould KL, Carabello BA. Why angina in aortic stenosis with normal coronary arteriograms? Circulation 107, 3121 (2003).
39. Vincentelli A SS, Le Tourneau T, Six I et al. Acquired von Willebrand syndrome in aortic stenosis. N. Engl. J. Med. 349, 343-349 (2003).
40. Veyradier A BA, Wolf M, Giraud V et al. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 120, 346-353 (2001).
41. Roldan CA SB, Crawford MH. Value of the cardiovascular examination for detecting valvular heart disease in asymptomatic subjects. Am. J. Cardiol. 77, 1327-1331 (1996).
42. Munt B. Physical examination in valvular aortic stenosis: Correlation with stenosis severity and prediction of clinical outcome. Am. Heart J. 137, 298-306 (1999).
43. Forssell G JR, Orinius E. Identifying severe aortic valvular stenosis by bedside examination. Acta Med. Scand. 218, 397-400 (1985).
44. Aronow WS, Kronzon I. Correlation of prevalence and severity of valvular aortic stenosis determined by continuous-wave doppler echocardiography with physical signs of aortic stenosis in patients aged 62 to 100 years with aortic systolic ejection murmurs. Am. J. Cardiol. 60, 399-401 (1987).
45. Szamosi A, Wassberg B. Radiologic detection of aortic stenosis. Acta Radiol. Diagn. Stockholm 24, 201-207 (1983).
46. Richards AM, Nicholls MG, Ikram H, Hamilton EJ, Richards RD. Syncope in acute valvular stenosis. Lancet 2, 1113-1116 (1984).
47. Michel PL, Mandagout O, Vahanian A et al. Ventricular arrhythmias in aortic valve disease before and after aortic valve replacement. Acta Cardiol. 47, 145-156 (1992).
48. von Olshausen K, Schwarz F, Apfellbach J et al. Determinants of the incidence and severity of ventricular arrhythmias in aortic valve disease. Am. J. Cardiol. 51, 1103-1109 (1983).
49. Turina J, Hess OM, Krayenbuhl HP. Spontaneous course of aortic valve disease. Eur. Heart J. 8, 471-483 (1987).
50. Faggiano P, Ghizzoni G, Sorgato A et al. Rate of progression of valvular aortic stenosis in adults. Am. J. Cardiol. 70, 229-233 (1992).
51. Otto CM, Burwash IG, Legget ME et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 95, 2262-2270 (1997).
52. Rosenhek R, Binder T, Porenta G et al. Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis. N. Engl. J. Med. 343, 611-617 (2000).
53. Pellikka PA NR, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J. Am. Coll. Cardiol. 15, 1012-1017 (1990).
54. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. Do asymptomatic patients with significant aortic stenosis have cardiac death? Follow-up of 610 patients. Eur. Heart J. 22(Suppl.), 492 (2001).
55. Otto CM. Textbook of Clinical Echocardiography. Otto CM (Ed.), W.B. Saunders Company, PA, USA 232-248 (2000).
56. Shavelle DM OC. Aortic stenosis: Echocardiographic evaluation of disease severity, disease progression, and the role of echocardiiography in clincal decision making. In: The Practice of Clinical Echocardiography CM O (Ed.) WB Saunders, PA, USA (2002).
57. Chen L, Otto CM. Longitudinal assessment of valvular heart disease by echocardiography. Curr. Opin. Cardiol. 13, 397-403 (1998).
58. Bernard Y MN, Vuillemenot A, Magnin D et al. Planimetry of aortic valve area using multiplane transesophageal echocardiography is not a reliable method for assessing severity of aortic stenosis. Heart 78, 68-73 (1997).
59. Cormier B, Iung B, Porte JM, Barbant S, Vahanian A. Value of multiplane trnasesophageal echocardiography in determining aortic valve area in aortic stenosis. Am. J. Cardiol. 77, 882-885 (1996).
60. Omran H, Schmidt H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prosepctive, randomized study. Lancet 361, 1241-1246 (2003).
61. Georgeson S, Meyer KB, Pauker SG. Decision analysis in clinical cardiology: when is coronary angiography required in aortic stenosis. J. Am. Coll. Cardiol. 15, 751-762 (1990).
62. Shavelle DM, Budoff MJ, Buljubasic N et al. Usefulness of aortic valve calcium scores by electron beam computed tomography as a marker for aortic stenosis. Am. J. Cardiol. 92, 349-353 (2003).
63. John AS, Dill T, Brandt RR et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J. Am. Coll. Cardiol. 42, 519-526 (2003).
64. Cowell SJ, Newby DE, Burton J et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin. Radiol. 58, 712-716 (2003).
65. Hatle L, Angelsen BA, Tromsdal A. Non-invasive assessment of aortic stenosis by Doppler ultrasound. Br. Heart J. 43, 284-292.
66. Davies SW, Gershlick AH, Balcon R. Progression of valvular aortic stenosis. A long term retrospective study. Eur. Heart J. 12, 10-14 (1991).
67. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J. Am. Coll. Cardiol. 13, 545-550 (1989).
68. Roger VL, Tajik AJ, Bailey KR et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am. Heart J. 119, 331-338 (1990).
69. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular AS in adults: literature review and clinical implications. Am. Heart J. 132, 408-417 (1996).
70. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis: role of age and concomitant coronary artery disease. Chest 103, 1715-1719 (1993).
71. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J. Am. Coll. Cardiol. 25, 305-310 (1995).
72. Bahler. Factors leading to progression of valvular aortic stenosis. Am. J. Cardiol. 84, 1044-1048 (1999).
73. Palta. New insights into the progression of aortic stenosis. Circulation 101, 2497-2502 (2000).
74. Lester SJ, McElhinney DB, Miller JP et al. Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis. Circulation 101, 1947-1952 (2000).
75. Monin JL, Monchi M, Gest V et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardigoraphy. J. Am. Coll. Cardiol. 37, 2101-2107 (2001).
76. deFilippi CR, Willett DL, Brickner ME et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am. J. Cardiol. 75, 191-194 (1995).
77. Nishimura RA, Grantham JA, Connolly HM et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106, 809-813 (2002).
78. Monin JL QJ, Monchi M, Petit H, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108, 319-324 (2003).
79. Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J. Heart Valve Dis. 11, 204-209 (2002).
80. Chambers J. Exercise testing to guide surgery in aortic stenosis. Heart 82, 7-8 (1999).
81. Clyne CA, Arrighi JA, Maron BJ et al. Systemic and left ventricular responses to exercise stress of asymptomatic patients with valvular aortic stenosis. Am. J. Cardiol. 68, 1469-1476 (1991).
82. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testing in patients with aortic stenosis. Chest 93, 1083-1087 (1988).
83. Otto CM, Pearlman AS, Kraft CD. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J. Am. Coll. Cardiol. 20, 1160-1167 (1992).
84. Linderholm H, Osterman G, Teien D. Detection of coronary artery disease by means of exercise ECG in patients with aortic stenosis. Acta Med. Scand. 218 (1985).
85. Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA Guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on exercise testing). J. Am. Coll. Cardiol. 30, 260-315 (1997).
86. Gerber IL, Stewart RA, Legget ME et al. Increased plasma naturetic levels reflect symptom onset in aortic stenosis. Circulation 107, 1884-1890 (2003).
87. Lund O, Nielsen TT, Emmertsen K et al. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac. Cardiovasc. Surg. 44, 289-295.
88. Craver JM, Weintraub WS, Jones EL et al. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation 78, 285-290 (1988).
89. Sethi GK, Miller DC, Souchek J et al. Clinical, hemodynamic, and angiographic predictors of operative mortality in patients undergoing single valve replacement. J. Thorac. Cardiovasc. Surg. 93, 884-897 (1987).
90. Otto CM, Timing of aortic valve surgery. Heart 84, 211-218 (2000).
91. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N. Engl. J. Med. 324, 573-579 (1991).
92. Hammermeister KE, Sethi GK, Henderson WG et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis: Veterans Affairs Cooperative Study on Valvular Heart Disease. N. Engl. J. Med. 328, 1289-1296 (1993).
93. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention. Circulation 1990; 82:124-139.
94. Vaturi M, Porter A, Adler Y et al. The Natural History of Aortic Valve Disease after Mitral Valve Surgery. J. Am. Coll. Cardiol. 33, 2003-2008 (1999).
95. Pibarot P, Dumesnil JG, Leblanc MH, Cartier P, Metras J. Changes in left ventricular mass and function after aortic valve replacement: a comparison between stentless and stented bioprosthetic valves. J. Am. Soc. Echocardiogr. 12, 981-987 (1999).
96. Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation 89, 642-650 (1994).
97. Brady ST, Davis CA, Kussmaul WG et al. Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality. Ann. Intern. Med. 110, 761-766 (1989).
98. Lieberman EB, Bashore TM, Hermiller JB et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long term outcome. J. Am. Coll. Cardiol. 26, 1522-1528 (1995).
99. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 10, 106(24), 3006-3008 (2002).
100. Novaro GM, Tiong IY, Pearce GL et al. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcitic aortic stenosis. Circulation 104, 2205-2209 (2001).
101. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme A reductase inhibitor treatment, and progression of aortic stenosis in community. J. Am. Coll. Cardiol. 40, 1731-1734 (2002).
102. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever. Pediatrics 96, 758-764 (1995).
103. Aranki SF, Rizzo RJ, Couper GS et al. Aortic valve replacement in the elderly; effect of gender and coronary artery disease on operative mortality. Circulation 88(2), 17-23 (1993).
104. Galloway AC, Colvin SB, Grossi EA et al. Ten-year experience with aortic valve replacement in 482 patients 70 years of age or older: operative risk and long term results. Ann. Thorac. Surg. 49, 84-93 (1990).
105. Bouma B. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 82, 143-448 (1999).
106. Lindblom D, Lindblom U, Qvist J, Lundstrom H. Long-term relative survival rates after heart valve replacement. J. Am. Coll. Cardiol. 15, 566-573 (1990).
107. Torsher LC SC, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardia surgery. Am. J. Cardiol. 81, 448-452 (1998).
108. Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery. Can. J. Anaesth. 45, 855-859 (1998).
109. Siu SC, Sermer M, Colman JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104, 515-521 (2001).
110. Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. Am. Coll. Cardiol. 37, 893-899 (2001).
111. Easterling TR, Chadwick HS, Otto CM, Benedetti TJ. Aortic stenosis in pregnancy. Obstet. Gynecol. 72, 113-118 (1988).